Literature DB >> 11177726

What's New in beta-lactamases?

Patricia A. Bradford1.   

Abstract

beta-lactamases continue to be the leading cause of resistance to beta-lactam antibiotics, among gram-negative bacteria. In recent years, both the incidence and the prevalence of extended-spectrum beta-lactamases, inhibitor-resistant beta-lactamases, AmpC-type enzymes, and both metallo- carbapenemases and nonmetallo-carbapenemases have increased. These beta-lactamases provide resistance to oximino-cephalosporins, beta-lactam/beta-lactamase inhibitor combinations, cephamycins, and carbapenems, respectively. Strains expressing these beta-lactamases will generate a host of therapeutic challenges as we begin the 21st century.

Entities:  

Year:  2001        PMID： 11177726     DOI： 10.1007/s11908-001-0054-z

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


  67 in total

1.  Carbapenem-hydrolysing IMP-1 beta-lactamase in Klebsiella pneumoniae from Singapore.

Authors:  T H Koh; G S Babini; N Woodford; L H Sng; L M Hall; D M Livermore
Journal:  Lancet       Date:  1999-06-19       Impact factor: 79.321

2.  Sequence of the MIR-1 beta-lactamase gene.

Authors:  G A Jacoby; J Tran
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

3.  Antimicrobial resistance and spread of class 1 integrons among Salmonella serotypes.

Authors:  B Guerra; S Soto; S Cal; M C Mendoza
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

4.  Emergence of resistance to third-generation cephalosporins amongst Salmonella typhimurium isolates in Greece: report of the first three cases.

Authors:  L S Tzouvelekis; M Gazouli; A Markogiannakis; E Paraskaki; N J Legakis; E Tzelepi
Journal:  J Antimicrob Chemother       Date:  1998-08       Impact factor: 5.790

5.  Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction.

Authors:  E Miró; M del Cuerpo; F Navarro; M Sabaté; B Mirelis; G Prats
Journal:  J Antimicrob Chemother       Date:  1998-10       Impact factor: 5.790

6.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

Authors:  V Jarlier; M H Nicolas; G Fournier; A Philippon
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

7.  Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.

Authors:  L Poirel; T Naas; D Nicolas; L Collet; S Bellais; J D Cavallo; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

8.  Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.

Authors:  J Wiener; J P Quinn; P A Bradford; R V Goering; C Nathan; K Bush; R A Weinstein
Journal:  JAMA       Date:  1999-02-10       Impact factor: 56.272

Review 9.  Metallo-beta-lactamases: a class apart.

Authors:  K Bush
Journal:  Clin Infect Dis       Date:  1998-08       Impact factor: 9.079

10.  Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance.

Authors:  E Osano; Y Arakawa; R Wacharotayankun; M Ohta; T Horii; H Ito; F Yoshimura; N Kato
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191
View more
  3 in total

1.  Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals.

Authors:  Ellen Smith Moland; Jennifer A Black; Jason Ourada; Mark D Reisbig; Nancy D Hanson; Kenneth S Thomson
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

2.  Role of a mutation at position 167 of CTX-M-19 in ceftazidime hydrolysis.

Authors:  Soichiro Kimura; Masaji Ishiguro; Yoshikazu Ishii; Jimena Alba; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

3.  Structural Variabilities in β-Lactamase (blaA) of Different Biovars of Yersinia enterocolitica: Implications for β-Lactam Antibiotic and β-Lactamase Inhibitor Susceptibilities.

Authors:  Neelja Singhal; Abhishikha Srivastava; Manish Kumar; Jugsharan Singh Virdi
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.